Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Risk governance

This article was originally published in The Gray Sheet

Executive Summary

Spurred by high-profile events like the European BSE crisis, Eucomed is planning to use its risk management paper as a lobbying tool in coming years. Prepared in response to the European Commission's 1"Communication from the Commission on the Precautionary Principle" and 2"European Governance - A White Paper", the association's "Risk Governance as applied to Medical Technology Products" will target policymakers who desire "zero risk, something which rarely exists," Eucomed says. Eucomed expects the paper, currently in development, to provide an overview of the risk management approach applied by industry. The European device trade group has completed scientific evaluation of the paper but is still conducting a political analysis...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT016779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel